PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations
Hélène Vanacker, Philipp Harter, Sana Intidhar Labidi‐Galy, Susana Banerjee, Ana Oaknin, Domenica Lorusso, Isabelle Ray‐Coquard
Topics & Concepts
MedicineOlaparibOvarian cancerSynthetic lethalityPARP inhibitorSerous fluidCancer researchMaintenance therapyDiseaseOncologyPoly ADP ribose polymeraseCancerDNA repairInternal medicineChemotherapyPolymeraseDNABiologyGeneticsPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentPlant Virus Research Studies